1 documents found
Information × Registration Number 0219U000017, 0115U002970 , R & D reports Title Experimental justification of CD150 isoforms application as potential diagnostic markers and targets for directed anti-tumor therapy popup.stage_title Head Sidorenko Svitlana Pavlivna, Доктор біологічних наук Registration Date 08-01-2019 Organization R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology popup.description2 We study the biological properties of 293-T cells with differential expression of nCD150 (293-T_nCD150) or mCD150 (293-T_mCD150) isoforms CD150 comparatively to non-expressing CD150 cells 293-T. It has been found that 293-T cells that do not express CD150 have less proliferative potential, viability and colony formation against 293-T_nCD150 and 293-T_mCD150 cells. 293-T cells expressing the nCD150 isoform have higher viability, colony-forming properties, CD150 expression at protein levels and less proliferative activity than cells 293-T_mCD150. Product Description popup.authors Ковалевська Лариса Миколаївна Сидоренко Світлана Павлівна Шлапацька Лариса Миколаївна popup.nrat_date 2020-04-02 Close
R & D report
Head: Sidorenko Svitlana Pavlivna. Experimental justification of CD150 isoforms application as potential diagnostic markers and targets for directed anti-tumor therapy. (popup.stage: ). R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology. № 0219U000017
1 documents found

Updated: 2026-03-26